[en] We have generated 10 alanine mutants of human PRL (hPRL), a member of the PRL/GH family, to investigate the involvement of the highly conserved 58-74 region in the biological behavior of the protein. When treated with polyclonal anti-hPRL antibodies, all mutants were immunologically indistinguishable from the unmodified hPRL, and circular dichroism analyses indicated that their alpha-helix content was similar to that of the unmodified hormone. Mutations C58A, K69A, and, to a lesser extent, P66A affected drastically the ability of hPRL first to bind to the lactogenic receptor and second to stimulate the proliferation of Nb2 lymphoma cells, proving the importance of the 58-74 peptide segment for hPRL bioactivity. Binding affinities of these mutants to the Nb2 lactogenic receptor have been compared to lactogenic binding data previously obtained for several mutants of hGH. The comparison reveals that the residues involved in the biological properties of the two proteins are not at topologically equivalent positions. Hence, we suggest that the binding of these hormones to the lactogenic receptors occurs through a different molecular mechanism having distinct requirements at the residue level.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Goffin, V.; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire
Golander A, Richards R, Thraikill K, Capel D, Rogers D, Hanwerger S 1988 Decidual prolactin (PRL)-releasing factor stimulates the synthesis of PRL from human decidual cells. Endocrinology 123:335-339
Nicoll CS, Bern HA 1972 On the action of prolactin among the vertebrates: is there a common denominator? In Wolsten-Holme GEW, Knight J (eds) Lactogenic Hormones. Churchill-Livingston, London, pp 299-317
Miller WL, Eberhardt NL 1983 Structure and evolution of the growth hormone gene family. Endocr Rev 4:97-129
Abdel-Meguid SS, Shieh HS, Smith WW, Dayringer HE, Violand BN, Bentle LA 1987 Three-dimensional structure of a genetically engineered variant of porcine growth hormone. Proc Natl Acad Sci USA 84:6434-6437
de Vos AM, Ultsch M, Kossiakoff AA 1992 Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-312
Boutin JM, Jolicoeur C, Okamura H, Gagnon J, Edery M, Shirota M, Banville D, Dusanter-Fourt I, Djiane J, Kelly PA 1988 Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell 53:69-77
Edery M, Jolicoeur C, Levi-Meyrueis C, Dusanter-Fourt I, Petridou B, Boutin JM, Lesueur L, Kelly PA 1989 Identification and sequence analysis of a second form of prolactin receptor by molecular cloning of complementary DNA from rabbit mammary gland. Proc Natl Acad Sci USA 86:2112-2116
Kelly PA, Djiane J, Boutin JM, Edery M 1990 La structure des recepteurs de la prolactine et de I’hormone de crois-sance est maintenant connue. Med/Sci 6:778-784
Tanaka T, Shiu RPC, Gout PW, Beer CT, Noble RL, Friesen HG 1980 A new sensitive and specific bioassay for lactogenic hormones: measurements of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 51:1058-1063
Cunningham BC, Jhurani P, Ng P, Wells JA 1989 Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science 243:1330-1336
Cunningham BC, Wells JA 1989 High resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science 244:1081-1084
Nicoll CS, Mayer GL, Russell SM 1986 Structural features of prolactins and growth hormones that can be related to their biological properties. Endocr Rev 7(2):169-203
Binder L, Gertler A, Elberg G, Guy R, Vogel T 1990 Site-directed mutations of human growth hormone that selectively modify its lactogenic activity and binding properties. Mol Endocrinol 4:1060-1068
Gertler A, Shamay A, Cohen N, Ashkenazi A, Friesen HG, Levanon A, Gorecki M, Aviv H, Hadary D, Vogel T 1986 Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH. Endocrinology 118:720-726
Binder L, Vogel T, Hadary D, Elberg G, Gertler A 1989 Chimeric bovine-human growth hormone prepared by recombinant DNA technology: binding properties and biological activity. Mol Endocrinol 3:923-930
Luck DN, Gout PW, Beer CT, Smith M 1989 Bioactive recombinant methionyl bovine prolactin: structure-func-tion studies using site-specific mutagenesis. Mol Endocrinol 3:822-831
Luck DN, Gout PW, Kelsay K, Atkinson T, Beer CT, Smith M 1990 Recombinant bovine prolactin: loss of bioactivity after single amino acid deletions from putative helical regions. Mol Endocrinol 4:1011-1016
Clapp C, Sears PS, Russell DH, Richards J, Levay-Young BK, Nicoll CS 1988 Biological and immunological characterization of cleaved and 16K forms of rat prolactin. Endocrinology 122:2892-2898
Davis JA, Linzer DIH 1989 Mutational analysis of a lactogenic hormone reveals a role for lactogen-specific amino acid residues in receptor binding and mitogenic activity. Mol Endocrinol 3:1987-1995
Luck DN, Huyer M, Gout PW, Beer CT, Smith M 1991 Single amino acid substitutions in recombinant bovine prolactin that markedly reduce its mitogenic activity in Nb2 cell cultures. Mol Endocrinol 5:1880-1886
Davis JA, Linzer DIH 1989 A mutant lactogenic hormone that binds, but does not activate, the prolactin receptor. Mol Endocrinol 3:949-953
Ray J, Okamura H, Kelly PA, Liebhaber SA, Cooke NE 1990 Alteration in the receptor binding specificity of human growth hormone by genomic exon exchange. Mol Endocrinol 4:101-107
Roguin LP, Cohen CE, Retegui LA 1990 Monoclonal antibodies as probe to study the human growth hormone-binding domain to lactogenic rat liver receptors. Endocrinology 127:1009-1015
Cunningham BC, Wells JA 1991 Rational design of receptor-specific variants of human growth hormone. Proc Natl Acad Sci USA 88:3407-3411
Paris N, Rentier-Delrue F, Defontaine A, Goffin V, Mercier L, Martial JA 1990 Bacterial production and purification of recombinant human prolactin. Biotechnol Appl Biochem 12:436-449
Thorun W, Maurer HR 1971 Molecular weight determination by polyacrylamide gel electrophoresis. In Maurer (Ed) Disc Electrophoresis and Related Techniques of Polyacrylamide Gel Electrophoresis. Walter de Gruyter, Berlin, pp 8-19
Chen Y, Yang JT, Martinez HM 1972 Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 11:4120-4131
Shiu RPC, Elsholtz HP, Tanaka T, Friesen HG, Gout PW, Beer CT, Noble RL 1983 Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line. Endocrinology 113:159-165
Ashkenazi A, Cohen R, Gertler A 1987 Characterization of lactogen receptors in lactogenic hormone-dependent and independent Nb2 lymphoma cell lines. FEBS Lett 210:51-55
Dayhoff MO 1976 Atlas of Protein Sequence and Structure. National Biomedical Research Foundation, Washington, DC, 5(Suppl 2): 120-121
Swindells MB, Thornton JM 1991 Structure prediction and modelling. Curr Opin Biotechnol 2:512-519
Cooke NE, Coit D, Shine J, Baxter J, Martial JA 1981 Human prolactin: cDNA structural analysis and evolutionary comparisons. J Biol Chem 256:4007-4016
Bewley TA, Brovetto-Cruz J, Li CH 1969 Human pituitary growth hormone. Physiochemical investigations of the native and reduced-alkylated protein. Biochemistry 8:4701-4708
Bewley TA, Li CH 1972 Circular dichroism studies on human pituitary growth hormone and ovine pituitary lactogenic hormone. Biochemistry 11:884-888
Holladay LA, Hammonds RG, Puett D 1974 Growth hormone conformation and conformational equilibria. Biochemistry 13:1653-1661
Kelly PA, Djiane J, Postel-Vinay M-C, Edery M 1991 The prolactin/growth hormone receptor family. Endocr Rev 12:235-251
Ray J, Okamura H, Kelly PA, Cooke NE, Liebhaber SA 1990 Human growth hormone variant demonstrates a receptor binding profile distinct from that of normal pituitary growth hormone. J Biol Chem 265:7939-7944
Cunningham BC, Bass S, Fuh G, Wells JA 1990 Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science 250:1709-1712
Sayers JR, Schmidt W, Eckstein F 1988 5'-3'-Exonu-cleases in phosphorothioate-based oligonucleotide-directed mutagenesis. Nucleic Acids Res 16:791-802
Higuchi R, Krummel B, Saiki RK 1988 A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interaction. Nucleic Acids Res 16:7351-7367
Mainkoth J, Wahl G 1984 Hybridization of nucleic acids immobilized on solid support. Anal Biochem 138:267-284
Studier FW, Moffat BA 1986 Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 189:113-130
Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-bindinq. Anal Biochem 72:248-254
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
Gout PW, Beer CT, Noble RL 1980 Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res 40:2433-2436
Salacinski PRP, McLean C, Sykes JEC, Clement-Jones VV, Lowry P 1981 lodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3α,6α-diphenyl glycoluril (lodogen). Anal Biochem 117:136-146
Munson PJ, Rodbard D 1980 LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239
